Metronidazole-Induced Encephalopathy in Alcoholic Liver Disease: A Diagnostic and Therapeutic Challenge
- PMID: 27471133
- DOI: 10.1016/j.jemermed.2016.05.038
Metronidazole-Induced Encephalopathy in Alcoholic Liver Disease: A Diagnostic and Therapeutic Challenge
Abstract
Background: Acute encephalopathy in a patient with alcoholic liver disease (ALD) is a commonly encountered emergency situation occurring most frequently due to liver failure precipitated by varying etiologies. Acute reversible cerebellar ataxia with confusion secondary to prolonged metronidazole use has been reported rarely as a cause of encephalopathy in patients with ALD.
Case report: We describe a decompensated ALD patient with recurrent pyogenic cholangitis associated with hepatolithiasis who presented to the emergency department with sudden-onset cerebellar ataxia with dysarthria and mental confusion after prolonged use of metronidazole. Magnetic resonance imaging (MRI) of the brain was suggestive of bilateral dentate nuclei hyper intensities on T2 and fluid-attenuated inversion recovery sections seen classically in metronidazole-induced encephalopathy (MIE). Decompensated liver cirrhosis resulted in decreased hepatic clearance and increased cerebrospinal fluid concentration of metronidazole leading to toxicity at a relatively low total cumulative dose of 22 g. Both the clinical symptoms and MRI brain changes were reversed at 7 days and 6 weeks, respectively, after discontinuation of metronidazole. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: A patient with ALD presenting with encephalopathy creates a diagnostic dilemma for the emergency physician regarding whether to continue metronidazole and treat for hepatic encephalopathy or to suspect for MIE and withhold the drug. Failure to timely discontinue metronidazole may worsen the associated hepatic encephalopathy in these patients. Liver cirrhosis patients have higher mean concentration of metronidazole and its metabolite in the blood, making it necessary to keep the cumulative dose of metronidazole to < 20 g in them.
Keywords: alcoholic liver disease; ataxia; cerebellar; metronidazole-induced encephalopathy; recurrent pyogenic cholangitis.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Reversible inferior colliculus lesion in metronidazole-induced encephalopathy: magnetic resonance findings on diffusion-weighted and fluid attenuated inversion recovery imaging.J Comput Assist Tomogr. 2009 Mar-Apr;33(2):305-8. doi: 10.1097/RCT.0b013e31817e6f58. J Comput Assist Tomogr. 2009. PMID: 19346865
-
Cerebellar ataxia following prolonged use of metronidazole: case report and literature review.Int J Infect Dis. 2008 Nov;12(6):e111-4. doi: 10.1016/j.ijid.2008.03.006. Epub 2008 Jun 3. Int J Infect Dis. 2008. PMID: 18511323 Review.
-
Metronidazole-induced encephalopathy in a patient with liver cirrhosis.Korean J Hepatol. 2011 Jun;17(2):157-60. doi: 10.3350/kjhep.2011.17.2.157. Korean J Hepatol. 2011. PMID: 21757988 Free PMC article.
-
Metronidazole induced cerebellar ataxia.Indian J Pharmacol. 2013 May-Jun;45(3):295-7. doi: 10.4103/0253-7613.111903. Indian J Pharmacol. 2013. PMID: 23833378 Free PMC article.
-
[A case of irreversible metronidazole encephalopathy during liver abscess treatment].Nihon Shokakibyo Gakkai Zasshi. 2023;120(10):858-867. doi: 10.11405/nisshoshi.120.858. Nihon Shokakibyo Gakkai Zasshi. 2023. PMID: 37821376 Japanese.
Cited by
-
Frequency and Risk Factor Analysis for Metronidazole-Associated Neurologic Adverse Events.J Gen Intern Med. 2024 May;39(6):912-920. doi: 10.1007/s11606-023-08566-w. Epub 2023 Dec 13. J Gen Intern Med. 2024. PMID: 38093026 Free PMC article.
-
Metronidazole-induced encephalopathy: a systematic review.J Neurol. 2020 Jan;267(1):1-13. doi: 10.1007/s00415-018-9147-6. Epub 2018 Dec 7. J Neurol. 2020. PMID: 30536109
-
A rare clinical presentation of metronidazole-induced dysarthria: a case report with literature review.Radiol Case Rep. 2025 Aug 19;20(11):5615-5616. doi: 10.1016/j.radcr.2025.07.035. eCollection 2025 Nov. Radiol Case Rep. 2025. PMID: 40895005 Free PMC article. No abstract available.
-
Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy.BMJ Case Rep. 2018 Apr 20;2018:bcr2017223463. doi: 10.1136/bcr-2017-223463. BMJ Case Rep. 2018. PMID: 29678819 Free PMC article.
-
A rare clinical presentation of metronidazole-induced dysarthria: A Case report with literature review.Radiol Case Rep. 2025 Mar 8;20(5):2355-2359. doi: 10.1016/j.radcr.2025.02.042. eCollection 2025 May. Radiol Case Rep. 2025. PMID: 40129781 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials